Video Experimental Relacionado

Updated: Feb 10, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Descubrimiento y desarrollo de inhibidores antibacterianos de peptidoglicano hidrolasa

Kyong Tkhe Fam¹, Pavan Kumar Chodisetti¹, Howard C Hang^1,2

¹Department of Immunology and Microbiology, Scripps Research, La Jolla, California 92037, United States.

ACS infectious diseases

|February 9, 2026

Resumen

Se necesitan nuevas estrategias antimicrobianas debido al aumento de la resistencia a los antibióticos. Esta revisión explora la orientación de las hidrolasas de peptidoglicanos bacterianos con inhibidores de moléculas pequeñas, un área poco explorada para desarrollar nuevos fármacos antibacterianos.

Área de la Ciencia:

Microbiología Microbiología.
Descubrimiento de Drogas Descubrimiento de Drogas
La bioquímica es la bioquímica.

Sus antecedentes:

El aumento de las infecciones bacterianas y la resistencia a los antibióticos requieren nuevos agentes antimicrobianos.
El peptidoglicano es crucial para la integridad de la pared celular bacteriana, regulada por enzimas de síntesis y remodelación.
Las enzimas de síntesis de peptidoglicanos son objetivos antibióticos establecidos, pero las hidrolasas siguen siendo poco exploradas.

Objetivo del estudio:

Revisar los avances recientes en el desarrollo de inhibidores de moléculas pequeñas dirigidos a las hidrolasas de peptidoglicano.
Para resaltar las hidrolasas de peptidoglicano como una clase de diana antimicrobiana prometedora, pero poco explorada.

Principales métodos:

Revisión de la literatura de las investigaciones recientes sobre los inhibidores de la peptidoglicano hidrolasa.
Análisis del papel de las hidrolasas de peptidoglicano en la fisiología bacteriana.
Exploración de estrategias de desarrollo de inhibidores de pequeñas moléculas.

Principales resultados:

Las hidrolasas de peptidoglicano juegan un papel clave en la remodelación de la pared celular bacteriana.
Los inhibidores de moléculas pequeñas dirigidos a estas enzimas muestran potencial como nuevos antimicrobianos.
Este enfoque ofrece una nueva vía para combatir las bacterias resistentes a los antibióticos.

Conclusiones:

Dirigirse a las hidrolasas de peptidoglicano representa una estrategia prometedora para el desarrollo de nuevos antimicrobianos.
Se justifica una mayor investigación sobre los inhibidores de moléculas pequeñas de estas enzimas.
Este enfoque podría proporcionar tratamientos efectivos contra las infecciones bacterianas resistentes.

Palabras clave:

antibacteriano y antibacteriano.El adyuvante antibiótico es un adyuvante antibiótico.pared celular de las paredes celulares.el inhibidor del inhibidor.El peptidoglicano es una hidrolasa peptidoglicana.molécula pequeña molécula pequeña molécula

Más Videos Relacionados

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

Videos de Conceptos Relacionados

Peptidoglycan Synthesis

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Sustainable Development

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.